Literature DB >> 22739772

Surgical treatment of symptomatic cerebral cavernous malformations in eloquent brain regions.

Maria Wostrack1, Ehab Shiban, Kathrin Harmening, Thomas Obermueller, Florian Ringel, Yu-Mi Ryang, Bernhard Meyer, Michael Stoffel.   

Abstract

BACKGROUND: Despite the increased risk of hemorrhage and deteriorating neurological function of once-bled cerebral cavernous malformations (CM), the management of eloquently located CMs remains controversial.
METHODS: All eloquently located CMs (n = 45) surgically treated between 03/2006 and 04/2011 in our department were consecutively evaluated. Eloquence was characterized according to Spetzler and Martin's definition. The following locations were approached: brainstem, n = 16; sensorimotor, n = 8; visual pathway, n = 7; cerebellum (deep nuclei and peduncles), n = 7; basal ganglia, n = 4, and language, n = 3. Follow-up data was available for 41 patients (91 %) with a median interval of 14 months. Outcomes were evaluated according to the Glasgow outcome and the modified Rankin scale.
RESULTS: Immediately after surgery, 47 % (n = 21) had a new deficit. At follow-up, 80 % (n = 36) recovered to at least preoperative status or were better than before surgery, 9 % (n = 4) exhibited a slight, and 7 % (n = 3) had a moderate neurological impairment. Only two cases (4 %) with a new permanent severe deficit were observed, both related to dorsal brainstem surgery. The outcome after the surgery of otherwise located brainstem CMs was as beneficial as that for non-brainstem CMs. Patients with initially poor neurological performance fared worse than oligosymptomatic patients.
CONCLUSIONS: Despite the high postoperative transient morbidity, the majority improved profoundly during follow-ups. Compared with natural history, surgical treatment should be considered for all eloquent symptomatic CMs. Dorsal brainstem location and poor preoperative neurological status are associated with an increased postoperative morbidity.

Entities:  

Mesh:

Year:  2012        PMID: 22739772     DOI: 10.1007/s00701-012-1411-4

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  3 in total

1.  Microsurgical treatment and outcome of pediatric supratentorial cerebral cavernous malformation.

Authors:  Jung-Hoon Noh; Kyung Rae Cho; Je Young Yeon; Ho Jun Seol; Hyung Jin Shin
Journal:  J Korean Neurosurg Soc       Date:  2014-09-30

Review 2.  Cerebral cavernous malformation remnants after surgery: a single-center series with long-term bleeding risk analysis.

Authors:  Marco M Fontanella; Edoardo Agosti; Luca Zanin; Lodovico Terzi di Bergamo; Francesco Doglietto
Journal:  Neurosurg Rev       Date:  2020-11-19       Impact factor: 3.042

3.  A systematic review and meta-analysis of surgeries performed for cerebral cavernous malformation-related epilepsy in pediatric patients.

Authors:  Xiangyu Gao; Kangyi Yue; Jidong Sun; Zheng Fang; Yuan Cao; Boyan Zhao; Haofuzi Zhang; Shuhui Dai; Lei Zhang; Peng Luo; Xiaofan Jiang
Journal:  Front Pediatr       Date:  2022-09-06       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.